American College of Cardiology

NOVEMBER 5, 2024

The idea that obesity increases the risk of heart failure seems like an obvious conclusion. After all, as the Framingham Heart Study clearly showed, obesity and overweight are significantly associated with a higher risk of hypertension, angina and coronary heart disease.

Heart Failure 45

Heart Failure Innovation Angina Obesity 45

MIBHS

FEBRUARY 15, 2025

This condition reduces blood flow to the heart, increasing the risk of angina (chest pain) and heart attacks. Coronary Artery Disease (CAD) : High blood pressure accelerates the development of CAD by promoting the buildup of plaques in the coronary arteries.

Blood Pressure 52

Blood Pressure Hypertension Chest Pain Aneurysm 52

Frontiers in Cardiovascular Medicine

NOVEMBER 17, 2024

BackgroundWeight-adjusted waist circumference index (WWI) is a novel index related to obesity and has been associated with the risk and prognosis of several diseases. Subgroup analyses revealed that the impact of WWI on myocardial infarction varied across different populations.

Myocardial Infarction 59

Myocardial Infarction Angina BMI Obesity 59

MIBHS

JULY 31, 2024

Unhealthy Coping Mechanisms When under constant stress, many people turn to unhealthy coping mechanisms like overeating, smoking, or excessive alcohol consumption – habits that can further exacerbate cardiovascular issues by contributing to obesity, high blood pressure, and other risk factors.

Blood Pressure 52

Blood Pressure Heart attacks Heart Attack Heart Rhythm 52

Cardiology Update

APRIL 9, 2024

STEP-HFpEF DM 5 ( NCT04916470 ) explored the effects of semaglutide in obesity-related HF with preserved ejection fraction (HFpEF) and type 2 diabetes. Investigators randomized 616 adult patients with HFpEF and obesity to receive either once weekly semaglutide (n=310) or placebo (n=306). of patients in the PCI group compared to 3.4%

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52

DAIC

FEBRUARY 29, 2024

ET Murphy Ballroom 4 Comparison of an "Inclisiran First" Strategy with Usual Care in Patients With Atherosclerotic Cardiovascular Disease: Results From the VICTORION-INITIATE Randomized Trial Targeting Weight Loss to Personalize the Prevention of Type 2 Diabetes Once-weekly Semaglutide in Patients with Heart Failure With Preserved Ejection Fraction, (..)

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

DAIC

JANUARY 23, 2024

1,12,13 While it is important to treat all known risk factors that contribute to ASCVD including high blood pressure, hyperlipidemia, diabetes, and obesity, physicians also need to recognize and treat systemic inflammation in CV disease. 35 Overall, the magnitudes of benefit seen from colchicine, 0.5 12 Importantly, colchicine, 0.5

Cardiovascular Disease 111

Cardiovascular Disease Heart attacks Heart Attack Coronary Artery Disease 111